MedTech Acquisition Corp Contracts & Agreements
62 Contracts & Agreements
- Business Finance (30 contracts)
- Business Operations (3)
- Human Resources (13)
- Mergers & Acquisitions (2)
- Uncategorized (14)
- Description of Securities (Filed With SEC on August 14, 2024)
- Second Amend (Filed With SEC on August 14, 2024)
- Amendment No. 1 to Warrant Agreement, dated June 26, 2024, by and between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on June 27, 2024)
- Form of Dealer Manager and Solicitation Agent Agreement (Filed With SEC on May 24, 2024)
- Form of Tender and Support Agreement, by and between the Company and Supporting Stockholders (Filed With SEC on May 24, 2024)
- Registration Rights Agreement, dated April 30, 2024, by and between TriSalus Life Sciences, Inc., and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on May 15, 2024)
- Warrant Certificate, dated April 30, 2024, by and between TriSalus Life Sciences, Inc., and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on May 15, 2024)
- Credit Agreement, dated April 30, 2024, by and between TriSalus Operating Life Sciences, Inc., TriSalus Life Sciences, Inc., and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on May 15, 2024)
- Description of Capital Stock (Filed With SEC on April 11, 2024)
- Executive Employment Agreement, Dated August 28, 2023, by and between TriSalus Life Sciences, Inc. and Jodi Devlin (Filed With SEC on April 11, 2024)
- Executive Employment Agreement, dated August 28, 2023, by and between TriSalus Life Sciences, Inc. and Jodi Devlin (Filed With SEC on October 19, 2023)
- Specimen Common Stock Certificate (Filed With SEC on August 16, 2023)
- Specimen Warrant Certificate (Filed With SEC on August 16, 2023)
- Description of Common Stock (Filed With SEC on August 16, 2023)
- Amended and Restated Registration Rights Agreement, dated August 10, 2023, by and among TriSalus Life Sciences, Inc., members of MedTech Acquisition Sponsor LLC, and certain... (Filed With SEC on August 16, 2023)
- Executive Employment Agreement, dated November 4, 2022, by and between TriSalus Life Sciences, Inc. and James Alecxih (Filed With SEC on August 16, 2023)
- Surefire Medical, Inc. 2009 Amended and Restated Equity Incentive Plan (Filed With SEC on August 16, 2023)
- Form of Stock Option Grant Notice and Form of Stock Option Agreement under Surefire Medical, Inc. 2009 Amended and Restated Equity Incentive Plan (Pre-2020) (Filed With SEC on August 16, 2023)
- Form of Early Exercise Stock Option Grant Notice and Form of Stock Option Agreement under Surefire Medical, Inc. 2009 Amended and Restated Equity Incentive Plan (for grants prior... (Filed With SEC on August 16, 2023)
- Form of Stock Option Grant Notice and Form of Stock Option Agreement under Surefire Medical, Inc. 2009 Amended and Restated Equity Incentive Plan (for grants after 2020) (Filed With SEC on August 16, 2023)
- Form of Early Exercise Stock Option Grant Notice and Form of Stock Option Agreement under Surefire Medical, Inc. 2009 Amended and Restated Equity Incentive Plan (for grants after... (Filed With SEC on August 16, 2023)
- Form of Restricted Stock Unit Grant Notice and Form of Restricted Stock Unit Agreement under Surefire Medical, Inc. 2009 Amended and Restated Equity Incentive Plan (Filed With SEC on August 16, 2023)
- TriSalus Life Sciences, Inc. 2023 Equity Incentive Plan (Filed With SEC on August 16, 2023)
- Form of Stock Option Grant Notice and Form of Stock Option Agreement under 2023 Equity Incentive Plan (Filed With SEC on August 16, 2023)
- Form of Restricted Stock Unit Grant Notice and Form of Restricted Stock Unit Agreement under 2023 Equity Incentive Plan (Filed With SEC on August 16, 2023)
- TriSalus Life Sciences, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on August 16, 2023)
- Form of Indemnification Agreement by and between the Company and its directors and executive officers (Filed With SEC on August 16, 2023)
- Non-Employee Director Compensation Policy (Filed With SEC on August 16, 2023)
- Promissory Note issued to MedTech Acquisition Sponsor LLC, dated June 15, 2023 (Filed With SEC on June 15, 2023)
- Form of Subscription Agreement (Filed With SEC on June 8, 2023)
- Backstop Letter Agreement, dated as of June 7, 2023, by and between MedTech Acquisition Corporation and MedTech Acquisition Sponsor LLC (Filed With SEC on June 8, 2023)
- Second Amendment to Agreement and Plan of Merger, dated as of May 13, 2023, by and among MedTech Acquisition Corporation, MTAC Merger Sub, Inc., and TriSalus Life Sciences, Inc (Filed With SEC on May 15, 2023)
- First Amendment to Agreement and Plan of Merger, dated as of April 4, 2023, by and among MedTech Acquisition Corporation, MTAC Merger Sub, Inc., and TriSalus Life Sciences, Inc (Filed With SEC on April 5, 2023)
- Amendment No. 1 to Term Sheet, dated as of March 4, 2023, by and among MedTech Acquisition Corporation, TriSalus Life Sciences, Inc. and Magnetar Capital LLC (Filed With SEC on March 8, 2023)
- Promissory Note issued to MedTech Acquisition Sponsor LLC, dated December 16, 2022 (Filed With SEC on December 19, 2022)
- Promissory Note issued to MedTech Acquisition Sponsor LLC, dated December 16, 2022 (Filed With SEC on December 19, 2022)
- Form of Amendment No. 1 to Promissory Note of the Company (Filed With SEC on December 2, 2022)
- Promissory Note of the Company, dated May 24, 2022 (Filed With SEC on May 26, 2022)
- Termination of Business Combination Agreement (Filed With SEC on March 10, 2022)
- Promissory Note, dated January 28, 2022 (Filed With SEC on January 28, 2022)
- Promissory Note, dated December 30, 2021 (Filed With SEC on December 30, 2021)
- Description of Registered Securities (Filed With SEC on March 31, 2021)
- Underwriting Agreement, dated December 17, 2020, by and between the Company, Raymond James & Associates, Inc (Filed With SEC on December 23, 2020)
- Warrant Agreement, dated December 17, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on December 23, 2020)
- Letter Agreement, dated December 17, 2020, by and among the Company, its officers, its directors and the Sponsor (Filed With SEC on December 23, 2020)
- Investment Management Trust Agreement, dated December 17, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on December 23, 2020)
- Registration Rights Agreement, dated December 17, 2020, by and between the Company and the Sponsor (Filed With SEC on December 23, 2020)
- Private Placement Warrants Purchase Agreement, dated December 17, 2020, by and between the Company and the Sponsor (Filed With SEC on December 23, 2020)
- Administrative Support Agreement, dated December 17, 2020, by and between the Company and the Sponsor (Filed With SEC on December 23, 2020)
- Form of Underwriting Agreement (Filed With SEC on December 9, 2020)
- Specimen Unit Certificate (Filed With SEC on December 9, 2020)
- Specimen Class A Common Stock Certificate (Filed With SEC on December 9, 2020)
- Specimen Warrant Certificate (Filed With SEC on December 9, 2020)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on December 9, 2020)
- Form of Letter Agreement among the Registrant and our officers directors and sponsor (Filed With SEC on December 9, 2020)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on December 9, 2020)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on December 9, 2020)
- Form of Private Placement Warrants Purchase Agreement between the Registrant and the sponsor (Filed With SEC on December 9, 2020)
- Form of Indemnity Agreement (Filed With SEC on December 9, 2020)
- Form of Administrative Service Agreement between the Registrant and the sponsor (Filed With SEC on December 9, 2020)
- Promissory Note, dated September 11, 2020, issued to the sponsor (Filed With SEC on November 30, 2020)
- Securities Subscription Agreement, dated September 11, 2020, between the Registrant and the sponsor (Filed With SEC on November 30, 2020)